Gabapentin enacarbil nciclovir It is clinically tested for

It is clinically tested for its role in the treatment of left ventricular systolic heart failure

[2H]C1([2H])N(C(C2C=CC=CC=2)C2C=CC(Cl)=CC=2)C([2H])([2H])C([2H])([2H])N(CCOCC(O)=O)C1([2H])[2H]

Co-treatment with SC-514 significantly enhances Fotemustine-induced cytotoxicity in all melanoma cell lines tested

is dopamine D2/5-HT1A receptor agonist potentially for the treatment of Parkinson's disease

Smiles: C1=NC=CN1C(C1C=CC=CC=1)C1C=CC(=CC=1)C1C=CC=CC=1

Gabapentin enacarbil nciclovir It is clinically tested forGabapentin enacarbil is a prodrug for the anticonvulsant and analgesic drug gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability, especially when taken with a fatty meal. Gabapentin enacarbil has passed human clinical trials for the treatment of restless legs syndrome, and initial results have shown it to be